In line with this, a recent study in heart failure with reduced ejection fraction patients also showed that ACE2 was higher in male than female patients, independent of the use of pharmacological therapies targeting the renin–angiotensin–aldosterone system [53]. This evidence concerns the gene ACE2 and heart failure.